Even when a topic feels awkward to discuss, The Urology Group physicians encourage patients to be open and honest in order to get the best treatment.
In response to the COVID-19 health issue, we are offering telehealth as well as in-person appointments. Click to learn more.
Drs. Gary Kirsh and Brooke Edwards share hopeful news for African Americans facing advanced prostate cancer. An FDA-approved immunotheraphy has been shown to provide additional overall survival benefit of 9.3 months for African-American men with advanced prostate cancer.
Paradoxical figures between rise in advance prostate cancer cases and decline in early stage are likely due to the changing landscape of screening and testing over the past 2 decades.
Although it’s still the top cause of cancer-related deaths for men over 60, prostate cancer is a disease that can often be treated if detected early. CLICK TO READ FULL ARTICLE.